4/18
01:18 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Sanford C. Bernstein from $9.00 to $2.50. They now have an "outperform" rating on the stock.
Neutral
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Sanford C. Bernstein from $9.00 to $2.50. They now have an "outperform" rating on the stock.
4/18
08:06 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $2.50 price target on the stock, down previously from $7.00.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $2.50 price target on the stock, down previously from $7.00.
4/18
08:04 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $15.00 to $8.00. They now have a "sector outperform" rating on the stock.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $15.00 to $8.00. They now have a "sector outperform" rating on the stock.
4/18
06:54 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18% [Yahoo! Finance]
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18% [Yahoo! Finance]
4/17
11:00 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
4/17
02:44 pm
pacb
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays [Yahoo! Finance]
Neutral
Report
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays [Yahoo! Finance]
4/16
08:20 am
pacb
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance [Yahoo! Finance]
High
Report
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance [Yahoo! Finance]
4/16
08:05 am
pacb
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
High
Report
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
4/10
03:56 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Barclays PLC from $8.00 to $3.00. They now have an "equal weight" rating on the stock.
Low
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Barclays PLC from $8.00 to $3.00. They now have an "equal weight" rating on the stock.
4/10
10:19 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
4/3
12:16 pm
pacb
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now [Yahoo! Finance]
Low
Report
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now [Yahoo! Finance]
4/3
08:17 am
pacb
Rare Stock Picks In March 2024 - From 24 Discerning Analysts [Seeking Alpha]
Low
Report
Rare Stock Picks In March 2024 - From 24 Discerning Analysts [Seeking Alpha]
3/27
08:21 am
pacb
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes [Yahoo! Finance]
Low
Report
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes [Yahoo! Finance]
3/27
08:00 am
pacb
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
Medium
Report
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
3/22
04:30 pm
pacb
PacBio Grants Equity Incentive Award to New Employee
Low
Report
PacBio Grants Equity Incentive Award to New Employee
3/20
02:16 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
3/19
12:54 pm
pacb
Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership [Seeking Alpha]
Medium
Report
Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership [Seeking Alpha]
3/13
10:33 am
pacb
Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis [Yahoo! Finance]
Medium
Report
Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis [Yahoo! Finance]
3/12
09:28 am
pacb
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions [Yahoo! Finance]
Medium
Report
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions [Yahoo! Finance]
3/12
09:05 am
pacb
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
High
Report
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
3/11
11:00 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
3/11
11:00 pm
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
3/7
07:48 am
pacb
Moligo Technologies Appoints John Kuijpers as Chief Business Officer [Yahoo! Finance]
Low
Report
Moligo Technologies Appoints John Kuijpers as Chief Business Officer [Yahoo! Finance]
3/7
12:13 am
pacb
Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB) [Yahoo! Finance]
Medium
Report
Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB) [Yahoo! Finance]
2/28
07:48 pm
pacb
Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides [Seeking Alpha]
Low
Report
Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides [Seeking Alpha]